Company Filing History:
Years Active: 2022
Title: Innovations of Poulami Samai in CRISPR-Cas DNA Editing
Introduction
Poulami Samai is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of genetic engineering, particularly in the area of CRISPR-Cas DNA editing. Her innovative work has led to the development of a patented method that enhances the precision of DNA modifications.
Latest Patents
Poulami Samai holds a patent for "Compositions and methods for transcription-based CRISPR-Cas DNA editing." This patent provides compositions and methods for cleaving a DNA sequence within a cell. The methods involve introducing a recombinant vector containing a CRISPR system into a cell. This system includes a CRISPR RNA (crRNA) that is targeted to a specific DNA sequence and is operatively linked to a promoter. Additionally, the system incorporates CRISPR-associated enzymes, including Cas 10, Cas6, and at least one Csm protein. Notably, Cas 10 cleaves the DNA sequence only during the transcription of the DNA sequence linked to the promoter. The patent also includes recombinant vectors for modifying cells, cells that contain these vectors, and kits that feature the modified vectors.
Career Highlights
Poulami Samai is affiliated with The Rockefeller University, where she continues her research and development in genetic engineering. Her work is at the forefront of scientific innovation, contributing to advancements in biotechnology and medicine.
Collaborations
Poulami collaborates with esteemed colleagues, including Luciano Marraffini and Gregory Goldberg. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Poulami Samai's contributions to CRISPR-Cas DNA editing exemplify the impact of innovative research in genetics. Her patented methods and ongoing work at The Rockefeller University position her as a key figure in the advancement of biotechnology.